(Q44263737)

1 December 2017

Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer (English)

1 reference

1 December 2017

0 references

1 reference

Kayoko Tsujino

1

1 reference

1 December 2017

Saeko Hirota

2

1 reference

1 December 2017

Masahiro Endo

3

1 reference

1 December 2017

Kayoko Obayashi

4

1 reference

1 December 2017

Yoshikazu Kotani

5

1 reference

1 December 2017

Miyako Satouchi

6

1 reference

1 December 2017

Tetsuji Kado

7

1 reference

1 December 2017

Yoshiki Takada

8

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

International Journal of Radiation Oncology Biology Physics

1 December 2017

1 reference

1 December 2017

55

1 reference

1 December 2017

1

1 reference

1 December 2017

110-115

1 reference

Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903807-5

7 January 2021

Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903807-5

7 January 2021

Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903807-5

7 January 2021

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903807-5

7 January 2021

Concurrent versus sequential radiotherapy for small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903807-5

7 January 2021

Effect of cancer chemotherapeutic drugs on radiation-induced lung damage in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903807-5

7 January 2021

Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903807-5

7 January 2021

Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903807-5

7 January 2021

Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903807-5

7 January 2021

Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903807-5

7 January 2021

Risk factors of pneumonitis following chemoradiotherapy for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903807-5

7 January 2021

Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903807-5

7 January 2021

Risk factors of treatment-related death in chemotherapy and thoracic radiotherapy for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903807-5

7 January 2021

Irinotecan-associated pulmonary toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903807-5

7 January 2021

Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903807-5

7 January 2021

Radiation pneumonitis after breast cancer irradiation: analysis of the complication probability using the relative seriality model

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903807-5

7 January 2021

Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903807-5

7 January 2021

Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903807-5

7 January 2021

TGF-beta, radiation-induced pulmonary injury and lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903807-5

7 January 2021

Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903807-5

7 January 2021

Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2903807-5

7 January 2021

10.1016/S0360-3016(02)03807-5

Identifiers

DOI

1 reference

1 December 2017

1 reference